Becton Dickinson SG&A Expenses 2010-2024 | BDX

Becton Dickinson sg&a expenses for the twelve months ending September 30, 2024 were $4.858B, a 2.95% increase year-over-year.

  • Becton Dickinson annual sg&a expenses for 2024 were $4.857B, a 2.92% increase from 2023.
  • Becton Dickinson annual sg&a expenses for 2023 were $4.719B, a 0.21% increase from 2022.
  • Becton Dickinson annual sg&a expenses for 2022 were $4.709B, a 0.21% decline from 2021.

Becton Dickinson SG&A Expenses 2010-2024 | BDX

  • Becton Dickinson annual sg&a expenses for 2024 were $4.857B, a 2.92% increase from 2023.
  • Becton Dickinson annual sg&a expenses for 2023 were $4.719B, a 0.21% increase from 2022.
  • Becton Dickinson annual sg&a expenses for 2022 were $4.709B, a 0.21% decline from 2021.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$78.2B
Cardinal Health (CAH)$28.6B
West Pharmaceutical Services (WST)$22B
Labcorp (LH)$19.8B
Cooper (COO)$19.7B
Align Technology (ALGN)$16.6B
Henry Schein (HSIC)$9.3B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.8B
CONMED (CNMD)$2.2B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$170M
Pro-Dex (PDEX)$147M